10. Segment and Geographic Information

9 Months Ended

Dec. 31, 2015

Segment Reporting [Abstract]

Segment and Geographic Information

The Company generates product revenues from wound care products that are sold into the human and animal healthcare markets, and the Company generates service revenues from laboratory testing services, which are provided to medical device manufacturers.

The Company operates a single segment business for product revenues, which consists of three geographical sales territories as follows:

	Three Months				Nine Months
	Ended				Ended
	December 31,				December 31,
Geographic region	2015		2014		2015		2014
United States	$	1,010,000	$	647,000	$	2,983,000	$	1,358,000
Latin America		1,261,000		1,076,000		4,085,000		3,336,000
Europe and Rest of World		1,202,000		751,000		2,725,000		1,977,000
		3,473,000		2,474,000		9,793,000		6,671,000
Product license fees and royalties		120,000		555,000		906,000		2,601,000
Total product related revenues	$	3,593,000	$	3,029,000	$	10,699,000	$	9,272,000

The following table shows the Company’s product license fees and royalties revenues by partner:

	Three Months				Nine Months
	Ended				Ended
	December 31,				December 31,
Partner	2015		2014		2015		2014
Exeltis (formerly Quinnova)	$	44,000	$	54,000	$	201,000	$	361,000
Innovacyn		–		123,000		29,000		1,110,000
Laboratorios Sanfer (formerly More Pharma)		76,000		378,000		676,000		1,130,000
Total product license fees and royalties	$	120,000	$	555,000	$	906,000	$	2,601,000

The Company’s service revenues amounted to $227,000 and $189,000 for the three months ended December 31, 2015 and 2014, respectively.

The Company’s service revenues amounted to $855,000 and $602,000 for the nine months ended December 31, 2015 and 2014, respectively.